Autoantibodies predicting death due to cardiovascular disease

Cardiology
K AhoP Puska

Abstract

A randomly sampled population aged from 25 to 59 years and examined in 1972 was monitored for 5 years. During that period, 126 deaths from cardiovascular causes occurred among subjects with no recent history of major cardiovascular diseases. A control matched for age, sex and the conventional cardiovascular risk factors was assigned to each of the deceased subjects from the same population at risk. Rheumatoid factors or antinuclear antibodies as determined from the baseline specimens were found among 21 of the deceased (20 in the discordant pairs), but only in 7 controls (6 in the discordant pairs). This corresponds to a relative risk of death due to cardiovascular causes of 3.3 (p less than 0.01).

Citations

Jun 2, 2011·Nature Reviews. Rheumatology·Deborah P M Symmons, Sherine E Gabriel
Jan 18, 2012·Current Opinion in Rheumatology·Sherine E Gabriel, Cynthia S Crowson
Oct 1, 1995·Annals of the Rheumatic Diseases·M HeliövaaraA Reunanen
Oct 17, 2009·The Journal of Rheumatology·Kimberly P LiangSherine E Gabriel
Dec 2, 2014·Rheumatic Diseases Clinics of North America·Axel Finckh, Kevin D Deane
Mar 3, 2007·Arthritis and Rheumatism·John M DavisSherine E Gabriel
Dec 1, 1995·Seminars in Arthritis and Rheumatism·R A Myllykangas-LuosujärviH A Isomäki
May 1, 1985·Arthritis and Rheumatism·K AhoJ T Salonen
Jul 16, 1985·Biochemical and Biophysical Research Communications·S PaulS I Said
Jan 1, 1983·Acta Medica Scandinavica. Supplementum·B O Kristensen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Scandinavian Journal of Rheumatology
L E TrangO Walaas
Scandinavian Journal of Rheumatology
I LedenB Svensson
British Medical Journal
J W Shackle, W S Copeman
© 2021 Meta ULC. All rights reserved